Reimbursed Care Access in Solomon Islands

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. This country’s statutory framework for poisons and controlled drugs is set out in the Pharmacy and Poisons Act and related instruments which govern importation, possession and medical/clinical exemptions #.

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. Solomon Islands regulates controlled substances and poisons through the Pharmacy & Poisons legal framework that governs authorised medical imports and clinical use; no national medical approval pathway or reimbursement program for MDMA‑assisted therapy has been identified. #

No public regulatory approval, national procurement listing, or reimbursement pathway for intranasal esketamine (Spravato) could be identified in Solomon Islands public documentation. By contrast, national essential medicines/anaesthetic lists show inclusion of racemic ketamine for clinical anaesthesia but do not list esketamine or branded esketamine products, indicating absence of an established approval or public reimbursement pathway for esketamine. See national essential medicines listing showing Ketamine on anaesthetics list # and the national legislative framework for poisons and controlled drugs #.

Ketamine is an established, authorised medicinal anaesthetic in Solomon Islands and is listed on national essential medicines/anaesthetics lists used for public sector procurement and clinical use. The Solomon Islands Essential Medicines List includes ketamine 500 mg/10 ml injection under anaesthetics, indicating authorised clinical availability in government health facilities. #.

Regulatory/administrative framework: poisons and controlled medicines are governed by the Pharmacy & Poisons Act and related regulations maintained by the Attorney‑General’s/Ministry of Justice apparatus; clinical procurement and distribution in the public sector are managed via the Ministry of Health and Medical Services procurement systems which rely on the essential medicines list for budgeted purchases #.

Reimbursement and access nuance: explicit, line‑by‑line public insurance reimbursement schedules for specific medicines (including ketamine) are not published in central, publicly available policy documents; however, placement of ketamine on the national essential medicines/anaesthetics list indicates that it is procured for use in public hospitals and primary referral facilities under the national health supply system (i.e., publicly funded provision rather than a novel private psychedelic therapy market). There is no evidence of expanded psychedelic‑assisted therapy programs reimbursed by national schemes for ketamine beyond its established use as an anaesthetic and analgesic in clinical settings. # #.

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. National legislation governing poisons and controlled substances applies to internationally controlled psychotropic compounds such as DMT; no domestic medical approval or reimbursement program for DMT was identified. #

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. There is no public record of medical authorisation, clinical‑use guidance, or reimbursement for 5‑MeO‑DMT in Solomon Islands national documents. #

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. No national approval, regulated treatment programs, or reimbursement mechanisms for ibogaine were located in publicly available Solomon Islands sources. #

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. Preparations containing DMT (e.g., ayahuasca decoctions) are not recognised within the national medicines procurement or reimbursement frameworks; international treaty obligations and domestic poisons law govern control. #

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. There is no evidence of authorised medical mescaline products or reimbursement schemes in Solomon Islands public documentation. #

Currently classified as a strictly controlled substance under national drug scheduling and poisons legislation, with no authorized medical use outside of approved clinical research. No authorised medical framework or reimbursement for 2C‑series phenethylamines exists in national policy documents. #